Company
Certa Therapeutics
Taking control of fibrotic diseases through targeted therapeutics
Also known as Certa Therapeutics Pty Ltd
- Business model
- B2B
- Headquarters
- Melbourne, Australia
- Legal name
- Certa Therapeutics Pty Ltd
Record updated 28 September 2026
About
Certa Therapeutics novel drugs block a receptor that is a key driver of fibrosis (scarring) of the kidney and other organs. Certa is able to use genetic analysis to identify those patients that are most likely to benefit from therapy.
Products
- Web
- Asengeprast
- Other
- Asengeprast (FT011)